Overview

Efficacy and Safety of Anticoagulant Therapy in Portal Vein Thrombosis

Status:
Completed
Trial end date:
2020-01-31
Target enrollment:
Participant gender:
Summary
The study is aimed at evaluating the efficacy and safety of anticoagulant therapy with nadroparin calcium and warfarin in patients with portal vein thrombosis (PVT).
Phase:
Phase 4
Details
Lead Sponsor:
Qilu Hospital of Shandong University
Treatments:
Anticoagulants
Calcium
Calcium heparin
Dalteparin
Heparin
Heparin, Low-Molecular-Weight
Nadroparin
Warfarin